Roccatagliata G; Albano C; Maffini M; Farelli S (1980). «Alcohol withdrawal syndrome: treatment with trazodone». Int Pharmacopsychiatry15 (2): 105–10. doi:10.1159/000468420. PMID6108298.
«Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations». J Clin Psychopharmacol23 (4): 377–83. August 2003. doi:10.1097/01.jcp.0000085411.08426.d3. PMID12920414.
«Successful treatment of alcohol withdrawal with trazodone». Pharmacopsychiatry39 (6): 232. November 2006. doi:10.1055/s-2006-951385. PMID17124647.
«Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis». Br J Psychiatry197 (3): 174–9. September 2010. doi:10.1192/bjp.bp.109.067710. PMID20807960.
«Antidepressants in bipolar depression: yes, no, maybe?». Evid Based Ment Health18 (4): 100–2. November 2015. doi:10.1136/eb-2015-102229. PMID26459471.
«Persistent genital arousal disorder and trazodone. Morphometric and vascular modifications of the clitoris. A case report». J Sex Med6 (10): 2896–900. October 2009. doi:10.1111/j.1743-6109.2009.01418.x. PMID19674253.
«Investigation of a fatality due to trazodone poisoning: case report and literature review». J Anal Toxicol29 (4): 262–8. 2005. doi:10.1093/jat/29.4.262. PMID15975258.
«Fatal overdose with trazodone: case report and literature review». Acta Clin Belg56 (4): 258–61. 2001. doi:10.1179/acb.2001.038. PMID11603256.
Rakel RE (1987). «The greater safety of trazodone over tricyclic antidepressant agents: 5-year experience in the United States». Psychopathology20 (Suppl 1): 57–63. doi:10.1159/000284524. PMID3321131.
«Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS binding». J. Psychopharmacol. (Oxford)19 (3): 235–41. May 2005. doi:10.1177/0269881105051526. PMID15888508.
«Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications». Sleep Med Rev17 (4): 263–72. 2013. doi:10.1016/j.smrv.2012.08.001. PMID23357028.
«A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action». Psychopharmacology109 (1–2): 2–11. 1992. doi:10.1007/BF02245475. PMID1365657.
«Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis». CNS Drugs24 (1): 35–53. January 2010. doi:10.2165/11319480-000000000-00000. PMID20030418.
«Antidepressant-like effects of 5-hydroxytryptamine1A receptor agonists on operant responding under a response duration differentiation schedule». Behav Pharmacol9 (4): 309–18. July 1998. doi:10.1097/00008877-199807000-00002. PMID10065919.
Garattini, S (1985). «Active drug metabolites. An overview of their relevance in clinical pharmacokinetics.». Clinical Pharmacokinetics10 (3): 216–27. doi:10.2165/00003088-198510030-00002. PMID2861928.
«Trazodone, meta-chlorophenylpiperazine (an hallucinogenic drug and trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMIT®II ecstasy immunoassay in urine». J Anal Toxicol34 (9): 587–9. November 2010. doi:10.1093/jat/34.9.587. PMID21073812.
drugbank.ca
«Trazodone». DrugBank. Ανακτήθηκε στις 7 Ιουνίου 2015.
«Trazodone». www.drugbank.ca. Ανακτήθηκε στις 31 Ιανουαρίου 2019.
drugs.com
«Trazodone». Drugs.com (στα Αγγλικά). Ανακτήθηκε στις 9 Φεβρουαρίου 2019.
«Trazodone Hydrochloride». The American Society of Health-System Pharmacists. Ανακτήθηκε στις 8 Ιανουαρίου 2018.
Roccatagliata G; Albano C; Maffini M; Farelli S (1980). «Alcohol withdrawal syndrome: treatment with trazodone». Int Pharmacopsychiatry15 (2): 105–10. doi:10.1159/000468420. PMID6108298.
«Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations». J Clin Psychopharmacol23 (4): 377–83. August 2003. doi:10.1097/01.jcp.0000085411.08426.d3. PMID12920414.
«Successful treatment of alcohol withdrawal with trazodone». Pharmacopsychiatry39 (6): 232. November 2006. doi:10.1055/s-2006-951385. PMID17124647.
«Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis». Br J Psychiatry197 (3): 174–9. September 2010. doi:10.1192/bjp.bp.109.067710. PMID20807960.
«Antidepressants in bipolar depression: yes, no, maybe?». Evid Based Ment Health18 (4): 100–2. November 2015. doi:10.1136/eb-2015-102229. PMID26459471.
«The effects of moclobemide on cognition». J. Neural Transm. Suppl.28: 91–102. 1989. PMID2677245.
«Persistent genital arousal disorder and trazodone. Morphometric and vascular modifications of the clitoris. A case report». J Sex Med6 (10): 2896–900. October 2009. doi:10.1111/j.1743-6109.2009.01418.x. PMID19674253.
«Investigation of a fatality due to trazodone poisoning: case report and literature review». J Anal Toxicol29 (4): 262–8. 2005. doi:10.1093/jat/29.4.262. PMID15975258.
«Fatal overdose with trazodone: case report and literature review». Acta Clin Belg56 (4): 258–61. 2001. doi:10.1179/acb.2001.038. PMID11603256.
Rakel RE (1987). «The greater safety of trazodone over tricyclic antidepressant agents: 5-year experience in the United States». Psychopathology20 (Suppl 1): 57–63. doi:10.1159/000284524. PMID3321131.
«Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources». Drug Metab. Dispos.26 (6): 572–5. June 1998. PMID9616194.
«Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS binding». J. Psychopharmacol. (Oxford)19 (3): 235–41. May 2005. doi:10.1177/0269881105051526. PMID15888508.
«Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro». J. Pharmacol. Exp. Ther.230 (1): 94–102. 1984. PMID6086881.
«Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications». Sleep Med Rev17 (4): 263–72. 2013. doi:10.1016/j.smrv.2012.08.001. PMID23357028.
«A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action». Psychopharmacology109 (1–2): 2–11. 1992. doi:10.1007/BF02245475. PMID1365657.
«Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis». CNS Drugs24 (1): 35–53. January 2010. doi:10.2165/11319480-000000000-00000. PMID20030418.
«Antidepressant-like effects of 5-hydroxytryptamine1A receptor agonists on operant responding under a response duration differentiation schedule». Behav Pharmacol9 (4): 309–18. July 1998. doi:10.1097/00008877-199807000-00002. PMID10065919.
Garattini, S (1985). «Active drug metabolites. An overview of their relevance in clinical pharmacokinetics.». Clinical Pharmacokinetics10 (3): 216–27. doi:10.2165/00003088-198510030-00002. PMID2861928.
«[Pharmacokinetics and metabolism of trazodone in man (author's transl)]» (στα German). Arzneimittelforschung26 (11): 2084–9. 1976. PMID1037253.
«Trazodone, meta-chlorophenylpiperazine (an hallucinogenic drug and trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMIT®II ecstasy immunoassay in urine». J Anal Toxicol34 (9): 587–9. November 2010. doi:10.1093/jat/34.9.587. PMID21073812.
Roth, BL· Driscol, J. «PDSP Ki Database». Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Ανακτήθηκε στις 14 Αυγούστου 2017.